59
Participants
Start Date
July 4, 2017
Primary Completion Date
May 31, 2019
Study Completion Date
December 31, 2021
Defactinib
cross reference with arm/group descriptions
Pembrolizumab
cross reference with arm/group descriptions
RECRUITING
Belfast Health and Social Care Trust, Cancer Centre, Lisburn Road, Belfast
RECRUITING
Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh
RECRUITING
Beatson West of Scotland Cancer Centre, Glasgow
RECRUITING
Department of Cancer Studies, University of Leicester, Leicester Royal Infirmary, Leicester
RECRUITING
Cancer Research UK Centre, Southampton University Hospitals and University of Southampton, Southampton
Collaborators (1)
University of Glasgow
OTHER
Cancer Research UK
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
Verastem, Inc.
INDUSTRY
University of Edinburgh
OTHER
University of Southampton
OTHER
University of Leicester
OTHER
Queen's University, Belfast
OTHER
NHS Greater Glasgow and Clyde
OTHER